Nanotherapeutic that can cross blood-brain barrier reported in journal
The University of Delaware’s Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
Previously believed impossible, the groundbreaking development could have implications in the treatment of Glioblastoma multiforme (GBM), a lethal form of malignant brain tumors that is considered one of the deadliest human cancers. It may also benefit research for neurodegenerative diseases such as Parkinson’s disease, traumatic brain injury and multiple forms of cancer.
Led by researchers at Northwestern University, where Day conducted post-doctoral research, the team discovered that spherical nucleic acids (SNAs), tiny spherical gold nanoparticles densely coated with nucleic acids, have unique properties that allow them to pass through the blood-brain barrier and attack brain cancer.
The technology works by targeting Bcl2L12, a gene important in tumor progression.
“We believe that the SNA particles pass through by binding to scavenger receptors present in the cells lining the blood-brain barrier,” Day explained. “Once past the barrier, the SNA particles travel through the brain tissue and infiltrate tumor cells, where they interfere with the tumor cell’s genetic machinery to prevent the Bcl2L12 gene from being expressed.”
When administered systemically in cell and rodent models, the SNAs delivered nucleic acids to tumors without help from cationic carriers or other chemical modifications, lowered the expression of Bcl2L12 and effectively reduced tumor burden.
“Generally speaking we saw about a 20 percent increase in animal survival rates with this treatment, and a five-fold reduction in tumor growth without adverse side effects,” said Day, assistant professor of biomedical engineering at UD.
This discovery establishes SNAs as a promising new class of therapeutic gene regulation agents capable of treating disease through systemic injection, according to the research team’s findings published as a cover article in Science Translational Medicine, a publication of the American Association for the Advancement of Science.
Co-first authors on the paper were Day, Samuel Jensen and Caroline Ko, and their interdisciplinary team included researchers from Northwestern University’s departments of chemistry, biomedical engineering, molecular biosciences, neurology, neurobiology, and the International Institute for Nanotechnology. The research was led by Chad Mirkin, professor in Northwestern University’s Department of Chemistry, and Alexander Stegh, professor, in the Department of Neurology.
Future work on the project will include studies to determine safety and efficacy issues necessary for human trials and scaling the technology for manufacturing.
The Latest Google Headlines on:
The Latest Bing News on:
- Western United to raise funds for brain cancer in next Ballarat encounteron February 27, 2020 at 5:18 pm
Western United will unveil a new jersey for its round 25 fixture in Ballarat as a way to help fight brain cancer. The club and the Cure Brain Cancer Foundation will join forces with Kick It For Brain ...
- Former ESPN reporter Britt McHenry says she will need surgery for brain tumoron February 27, 2020 at 5:18 pm
Former ESPN reporter Brett McHenry announced Thursday that she has a brain tumor and will need surgery. McHenry, who currently works as a Fox News contributor and on the Fox Nation streaming service, ...
- Teen Basketball Star Recovering After Having Brain Tumor Removed Gets His Wishon February 27, 2020 at 5:16 pm
Antonio Sellers was a point forward for the Hudson Catholic varsity basketball team, but last year, he had surgery to remove a brain tumor and is still recovering. The teen is a huge Duke fan and ...
- Former ESPN reporter Britt McHenry announces she has brain tumoron February 27, 2020 at 5:14 pm
Fox News contributor and former ESPN reporter Britt McHenry announced on Thursday that she has a brain tumor. She made the announcement on Twitter. I was trying to keep this relatively private. But as ...
- Fox Nation host Britt McHenry, 33, reveals she has a brain tumoron February 27, 2020 at 5:01 pm
Britt McHenry, a contributor for Fox News, said "surgery is imminent" after revealing brain tumor diagnosis.
- Fox's Britt McHenry confirms brain tumor, says she's got 'amazing medical team'on February 27, 2020 at 4:58 pm
Fox News host Britt McHenry said Thursday she is getting treatment for a brain tumor. "I was trying to keep this relatively private. But as usual, things are being said without my consent," McHenry ...
- Britt McHenry reveals she has a brain tumoron February 27, 2020 at 4:25 pm
Britt McHenry shared some awful personal news on Thursday. McHenry, who was a reporter for ESPN from 2014 to 2017, shared that she has a brain tumor. She said that she will be undergoing surgery for ...
- N.J. student with brain cancer getting his wish to see U.N.C.-Duke basketball gameon February 27, 2020 at 3:49 pm
If Antonio Sellers could do anything in the world, he would see a basketball game. The 16-year-old Hudson Catholic basketball player, who has been battling brain cancer for a year, had always dreamed ...
- Incysus technology to treat brain cancer heads to Phase I trial at UABon February 27, 2020 at 11:43 am
Incysus Therapeutics, a local biopharmaceutical company focused on developing cancer treatments, has initiated a Phase I clinical study of a new brain cancer treatment. The trial for the drug ...
- Insilico Medicine taps GSK alum for a six-month AI sprint aimed at brain canceron February 27, 2020 at 9:29 am
Digital molecule designer Insilico Medicine has launched a preclinical research program focused on finding new treatments for brain cancer, and has brought on the former global program head of ...
The Latest Google Headlines on:
The Latest Bing News on:
- Gold nanoclusters: New frontier for developing medication for treatment of Alzheimer's diseaseon February 14, 2020 at 9:04 am
This article not only presents a compelling nanotherapeutic candidate for AD treatment, but also opens a new frontier for developing nanomaterial-based medications for AD treatment. Undoubtedly ...
- Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular burstson February 3, 2020 at 4:00 pm
1 Center for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5206, Boston, MA 02114, USA. 2 Department of Radiology, Massachusetts General Hospital, 55 Fruit Street, Boston ...
- A potent targeted cancer nanotherapeuticon February 2, 2020 at 4:00 pm
An antibody-modified nanoparticle encapsulating a pH-sensitive taxane prodrug, and targeting an overexpressed receptor in tumours, improves the tolerability and anticancer efficacy of the active ...
- Aphios Granted US Patent For Combination HIV Latency Nanotherapeutic Towards an HIV Cureon January 28, 2020 at 5:11 am
Aphios Corporation today announced that it was issued US Patent No. 10,493,030 for the treatment of HIV latency towards an HIV cure. This press release features multimedia. View the full release ...
- Aphios Granted US Patent For Combination HIV Latency Nanotherapeutic Towards an HIV Cureon January 27, 2020 at 4:00 pm
COMING UP: Iowa officials expected to release partial results of Democratic caucus. Click to watch full coverage … Aphios Corporation today announced that it was issued US Patent No. 10,493,030 ...